Tag: Cell therapy
Ultra-low Temperature Freezers Have Become Important for Today’s Cell and Gene Therapies
Ultra-Low Temperature Freezers (ULTs) can make an important contribution in the field of cell and gene therapies. For a long time, complex cryopreservation with liquid nitrogen was the standard for freezing all therapeutic substances. However, studies show that some...
UW – Madison Launches New Ophthalmology Tissue Biobank for Eye Diseases Research and Treatments
The University of Wisconsin Department of Ophthalmology and Visual Sciences (DOVS) has entered into a new partnership aimed at systematically collecting, storing, processing and distributing human eye tissue for research purposes. The new ‘tissue biobank’ will provide investigators with high-quality...
Using Ultra-Low Freezers to Maintain the Viability of Cell and Gene Therapy Products
Many cell and gene therapy solutions have shown considerable promise as a source of possible treatments for a wide range of chronic disorders. However, these sophisticated therapies introduce additional barriers such as the requirements for ultra-low and cryogenic storage,...
GoodCell Launches Personal Biobanking to Store Members’ Stem Cells for Future Personalized Therapies
GoodCell, a life sciences company, launched Personal Biobanking, a proactive, preventative healthcare service that allows members to store their own stem cells for potential future personalized therapy. Thousands of cell and gene therapies are in development to treat diseases and...
Stem Cell Banking: Current Trends, Benefits, Emerging Issues and Challenges
Recent scientific advancements have made stem cell therapy an emerging and promising area of research. The establishment of stem cell banks around the globe has been growing rapidly, aimed at preserving the characteristics of the cells, preventing contamination, and...
Allele Biotech to Collaborate with Cellatoz on Cell Therapy and iPSC Biobanking
Allele Biotechnology & Pharmaceuticals in San Diego, California, today announced the signing of a MOU with Cellatoz Therapeutics, a South Korean corporation, to form a business relationship on areas of mutual interest in the field of cell therapy. iPSC-based cell...
Design And Testing Of A Dendritic Cell Therapy Vaccine Against HIV-1
Infection with the human immunodeficiency virus 1 (HIV-1) is now a manageable condition, rather than a death sentence, as it once was. This is largely due to the development and commercialization of antiretroviral therapy (ART). In 2010 the annual...
The Gift Of Life Marrow Registry To Receive Advocacy Award At World Stem Cell...
The formal ceremony of the 2020 Stem Cell and Regenerative Medicine Action Awards will take place at a gala reception and dinner on January 23, during the 15th annual World Stem Cell Summit (WSCS) at the Hyatt Regency in...
Celyad’s Off-The-Shelf Cell Therapy CYAD-101 In Colorectal Cancer Dose-Escalation Phase 1 Trial
Celyad, a clinical-stage biopharmaceutical company focused
on the development of CAR-T cell therapies, has announced highlights from the
company’s NKG2D-based CAR-T clinical candidates for the treatment of metastatic
colorectal cancer (mCRC), including its novel, off-the-shelf cell therapy
CYAD-101 and alloSHRINK dose-escalation Phase 1...
ThermoGenesis X-Series® System Performance Validations Reported At Scientific Meetings
Cesca Therapeutics Inc., a market leader in automated cell processing and autologous cell therapies for regenerative medicine, and ThermoGenesis, its wholly owned device subsidiary have reported Validations of System Performance for their X-Series® products from two prestigious academic medical...
